Spots Global Cancer Trial Database for gastrointestinal stromal tumor, imatinib mesylate resistance, phase2 study, amg 706
Every month we try and update this database with for gastrointestinal stromal tumor, imatinib mesylate resistance, phase2 study, amg 706 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Evaluate the Efficacy of AMG 706 to Treat Advanced Gastrointestinal Stromal Tumors | NCT00254267 | Advanced Gastro... | AMG 706 | 20 Years - | Amgen | |
| Evaluate the Efficacy of AMG 706 to Treat Advanced Gastrointestinal Stromal Tumors | NCT00254267 | Advanced Gastro... | AMG 706 | 20 Years - | Amgen |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
